Editorial: Opportunities and challenges in drug repurposing
- PMID: 41132545
- PMCID: PMC12540431
- DOI: 10.3389/fphar.2025.1709217
Editorial: Opportunities and challenges in drug repurposing
Erratum in
-
Correction: Editorial: Opportunities and challenges in drug repurposing.Front Pharmacol. 2025 Nov 11;16:1735051. doi: 10.3389/fphar.2025.1735051. eCollection 2025. Front Pharmacol. 2025. PMID: 41306778 Free PMC article.
Keywords: artificial intelligence; bioinformatics; challenges; drug repositioning; drug repurposing; opportunities.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
-
- Maida J. (2024). Drug repurposing market to grow by USD 8.57 billion (2024-2028) as cancer treatment applications expand, AI-driven market transformation report – technavio. Cleveland, OH, United States: PR Newswire Website. Available online at: https://www.prnewswire.com/news-releases/drug-repurposing-market-to-grow... (Accessed September 17, 2025).
-
- Maximize Market Research (2017). Drug repurposing market: strategic approaches, technological advancements, market dynamics, and future growth outlook (2025–2032). Available online at: https://www.maximizemarketresearch.com/marketreport/drug-repurposing-mar... (Accessed September 17, 2025).
-
- Pinzi L., Bisi N., Rastelli G. (2024). How drug repurposing can advance drug discovery: challenges and opportunities. Front. Drug Discov. 4, 1460100. 10.3389/fddsv.2024.1460100 - DOI
Publication types
LinkOut - more resources
Full Text Sources
